> top > docs > PubMed:8055451 > annotations

PubMed:8055451 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T3 14-38 D002285 denotes ductal carcinoma in situ
T4 14-38 D002285 denotes ductal carcinoma in situ
T9 44-50 UBERON:0002030 denotes nipple
T10 87-96 D002277 denotes carcinoma
T11 87-96 D002277 denotes carcinoma
T12 137-143 UBERON:0000310 denotes breast
T15 199-223 D002285 denotes ductal carcinoma in situ
T16 199-223 D002285 denotes ductal carcinoma in situ
T22 225-229 CVCL_5552 denotes DCIS
T21 225-229 D002285 denotes DCIS
T23 225-229 D002285 denotes DCIS
T24 282-288 UBERON:0000310 denotes breast
T25 377-386 D002277 denotes carcinoma
T26 377-386 D002277 denotes carcinoma
T27 494-503 UBERON:2000106 denotes extension
T28 532-537 D009369 denotes tumor
T29 532-537 D009369 denotes tumor
T30 551-557 UBERON:0000310 denotes breast
T32 650-654 CVCL_5552 denotes DCIS
T31 650-654 D002285 denotes DCIS
T33 650-654 D002285 denotes DCIS
T34 761-765 UBERON:0000025 denotes Duct
T35 761-765 UBERON:0000058 denotes Duct
T36 852-858 UBERON:0002030 denotes nipple
T37 897-906 D002277 denotes carcinoma
T38 897-906 D002277 denotes carcinoma
T40 928-932 CVCL_5552 denotes DCIS
T39 928-932 D002285 denotes DCIS
T41 928-932 D002285 denotes DCIS
T42 1162-1171 D002277 denotes carcinoma
T43 1162-1171 D002277 denotes carcinoma
T44 1207-1216 D002277 denotes carcinoma
T45 1207-1216 D002277 denotes carcinoma
T47 1321-1325 CVCL_5552 denotes DCIS
T46 1321-1325 D002285 denotes DCIS
T48 1321-1325 D002285 denotes DCIS
T49 1336-1363 D002285 denotes atypical ductal hyperplasia
T50 1336-1363 D002285 denotes atypical ductal hyperplasia
T53 1395-1404 D002277 denotes carcinoma
T54 1395-1404 D002277 denotes carcinoma
T56 1516-1520 CVCL_5552 denotes DCIS
T55 1516-1520 D002285 denotes DCIS
T57 1516-1520 D002285 denotes DCIS
T58 1558-1569 D006965 denotes hyperplasia
T59 1558-1569 D006965 denotes hyperplasia
T61 1594-1598 CVCL_5552 denotes DCIS
T60 1594-1598 D002285 denotes DCIS
T62 1594-1598 D002285 denotes DCIS
T63 1747-1756 D002277 denotes carcinoma
T64 1747-1756 D002277 denotes carcinoma
T66 1934-1943 D002277 denotes carcinoma
T67 1934-1943 D002277 denotes carcinoma
T68 1983-1992 D002277 denotes carcinoma
T69 1983-1992 D002277 denotes carcinoma
T70 2032-2038 UBERON:0000310 denotes breast
T73 2076-2100 D002285 denotes ductal carcinoma in situ
T74 2076-2100 D002285 denotes ductal carcinoma in situ
T79 2106-2112 UBERON:0002030 denotes nipple

UseCases_ArguminSci_Discourse

Id Subject Object Predicate Lexical cue
T1 0-61 DRI_Background denotes Management of ductal carcinoma in situ with nipple discharge.
T2 62-163 DRI_Approach denotes Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
T3 176-333 DRI_Background denotes Surgical management of ductal carcinoma in situ (DCIS) has been a controversial issue in the selection of breast-conserving surgery as a method of treatment.
T4 334-558 DRI_Approach denotes The definition of intraductal spreading of carcinoma becomes an important factor in the decision making process, but little is known about how much intraductal extension influences the spreading of tumor in the whole breast.
T5 559-751 DRI_Outcome denotes To define any unfavorable pathologic factors existing in limited surgery for patients with DCIS, the authors investigated histopathologic characteristics using a sequential slicing of tissues.
T6 761-773 REPLACED denotes Duct-lobular
T7 774-787 Token_Label.OUTSIDE denotes segmentectomy
T8 787-869 DRI_Background denotes , a limited surgery, was performed on 110 patients with a bloody nipple discharge.
T9 870-974 DRI_Background denotes Six patients with invasive carcinoma and 17 patients with DCIS subsequently received a total mastectomy.
T10 975-1064 DRI_Background denotes The specimens obtained by segmentectomy and mastectomy were histopathologically examined.
T11 1065-1253 DRI_Background denotes Using subserial sections, the authors examined the relationship between intraductal spreading of carcinoma in the segmentectomy specimens and carcinoma residue in the mastectomy specimens.
T12 1263-1369 DRI_Background denotes Among 16 mastectomy specimens, the authors found residual DCIS in 6, and atypical ductal hyperplasia in 4.
T13 1370-1453 DRI_Background denotes Intraductal spreading of carcinoma was detected in 8 of 16 segmentectomy specimens.
T14 1454-1521 DRI_Approach denotes Six of eight patients with intraductal spreading had residual DCIS.
T15 1522-1581 DRI_Background denotes The other two patients had atypical hyperplasia in breasts.
T16 1582-1670 DRI_Outcome denotes No residual DCIS was detected in the other eight patients without intraductal spreading.
T17 1671-1785 DRI_Background denotes Among 12 patients under observation who did not have a mastectomy, invasive carcinoma subsequently developed in 3.
T18 1786-1861 DRI_Background denotes Two of three patients had intraductal spreading in segmentectomy specimens.
T19 1862-1944 DRI_Background denotes Only 1 of 10 patients without intraductal spreading, however, developed carcinoma.
T20 1958-2123 DRI_Background denotes Intraductal spreading of carcinoma is an unfavorable pathologic factor in breast-conserving surgery for patients with ductal carcinoma in situ with nipple discharge.